LearnDrugs.com
Nervous

Neuromuscular Blockers

High-yield High-alert Verified · Jul 2026

Prototype: succinylcholine

Neuromuscular blocking agents (NMBAs) — the paralytics used for intubation and surgery. Among the highest-alert drugs in the hospital.

How it works in the body

The system involved, what goes wrong, and how the drug and body interact.

01 The neuromuscular junction — where movement is commanded

Every voluntary muscle contracts on a chemical signal. A nerve releases acetylcholine (ACh) across the neuromuscular junction; ACh binds nicotinic receptors on the muscle, which fires and contracts. Block that step and the muscle cannot move — the basis of surgical paralysis and of holding a patient still for endotracheal intubation.

NMBAs act only on skeletal muscle. They do not touch the brain — so a paralyzed patient can be fully awake, aware, and in pain while unable to move or breathe. This single fact is the most important safety principle of the class.

02 Two ways to block — depolarizing vs non-depolarizing

Depolarizing blockers — essentially just succinylcholine — are ACh *mimics*. They bind the receptor and switch it on, causing a brief wave of muscle twitching (fasciculations), then keep it stuck "on" so it can’t reset — producing rapid paralysis. Succinylcholine’s ultra-fast onset and short duration make it ideal for rapid-sequence intubation, and it is broken down by plasma cholinesterase (not reversible with the usual agents).

Non-depolarizing blockers — rocuronium, vecuronium, cisatracurium (often "-curium/-curonium") — are competitive antagonists: they occupy the receptor and block ACh without activating it (no fasciculations). Their effect can be reversed: sugammadex directly encapsulates rocuronium/vecuronium, and acetylcholinesterase inhibitors (neostigmine) raise ACh to outcompete them.

Depolarizing agents over-activate the ACh receptor; non-depolarizing agents competitively block it.

03 The lethal pitfalls — awareness, malignant hyperthermia, hyperkalemia

Because paralysis without sedation is terrifying and dangerous, NMBAs are always paired with sedation and analgesia, and the patient must have a secured airway with ventilation — the diaphragm is a skeletal muscle, so the patient cannot breathe on their own.

Succinylcholine carries two specific dangers. It can trigger malignant hyperthermia — a genetic, life-threatening hypermetabolic crisis (rising CO₂, rigidity, soaring temperature) reversed with dantrolene. And by depolarizing muscle it releases potassium, so it is avoided in burns, crush injury, spinal cord injury, and myopathies where hyperkalemia could cause cardiac arrest. Its boxed warning describes fatal hyperkalemic arrest in children with undiagnosed muscular dystrophy — so routine pediatric use is restricted.

The non-negotiable NMBA safety bundle plus succinylcholine’s two specific dangers.

Drug names

Generic Brand
succinylcholine Anectine, Quelicin
rocuronium Zemuron
vecuronium —
cisatracurium Nimbex

Indications

  • Facilitation of endotracheal intubation (succinylcholine/rocuronium for rapid-sequence)
  • Skeletal muscle relaxation during surgery
  • Paralysis to facilitate mechanical ventilation (e.g., severe ARDS) in the ICU

Mechanism of action

Block nicotinic acetylcholine receptors at the neuromuscular junction. Depolarizing agents (succinylcholine) persistently activate the receptor (initial fasciculations → sustained depolarization → paralysis). Non-depolarizing agents (rocuronium, vecuronium, cisatracurium) competitively antagonize the receptor (no fasciculations; reversible).

In plain terms
They block the nerve-to-muscle signal so skeletal muscles go limp — used to intubate and to hold a patient still for surgery. They do NOT cause sleep or pain relief.

Therapeutic effects — what you'll see working

Success is exactly the right amount of paralysis at the right time — for intubation or surgery — while sedation and analgesia keep the patient unaware and comfortable, and a ventilator does the breathing. Depth is monitored with a train-of-four nerve stimulator.

Skeletal muscle paralysis Rapid intubating conditions
Skeletal muscle paralysis
Relaxes muscles to allow passage of an endotracheal tube and to keep the surgical field still — the sole therapeutic action.
Rapid intubating conditions
Succinylcholine (and high-dose rocuronium) produce excellent conditions within ~60 seconds for rapid-sequence intubation in emergencies.

Adverse effects

The adverse effects are the paralysis reaching muscles you didn’t intend (the diaphragm — apnea), the awareness risk if sedation is inadequate, and succinylcholine’s two specific catastrophes.

Caution: Common
Muscle fasciculations then post-op muscle pain (succinylcholine); prolonged weakness; histamine release/hypotension (some agents).
Succinylcholine’s fasciculations often cause post-operative muscle soreness. Some non-depolarizers release histamine, causing flushing and hypotension. Residual blockade can leave lingering weakness if not fully reversed.
Warning: Serious Report immediately
Respiratory arrest/apnea (always); awareness under inadequate sedation; malignant hyperthermia and hyperkalemia (succinylcholine); prolonged apnea (pseudocholinesterase deficiency).
Apnea is guaranteed — the diaphragm is paralyzed, so ventilation is mandatory. Without adequate sedation the patient experiences terrifying awareness. Succinylcholine can trigger malignant hyperthermia (dantrolene) and dangerous hyperkalemia; patients with pseudocholinesterase deficiency cannot break it down and stay paralyzed far longer.
Black-box warning — most severe: ■ Boxed warning · succinylcholine in children Report immediately
Rare fatal hyperkalemic rhabdomyolysis/cardiac arrest in children with undiagnosed skeletal myopathy.
Apparently healthy children (usually boys ≤ 8 y) with an undiagnosed myopathy (e.g., Duchenne) have died from acute rhabdomyolysis, hyperkalemia, and cardiac arrest after succinylcholine. Its use in children is therefore reserved for emergency intubation or when immediate airway control is needed.

Antidote

Neostigmine (or sugammadex)
Reverses nondepolarizing blockade only — neostigmine (an AChE inhibitor, give with an antimuscarinic) raises ACh to outcompete the blocker; sugammadex directly encapsulates rocuronium/vecuronium. Depolarizing succinylcholine is not reversible this way. For malignant hyperthermia, give dantrolene immediately.

Contraindications

The contraindications are almost all about succinylcholine and its potassium/malignant-hyperthermia risks — and the universal requirement for airway control.

No secured airway / inability to ventilate; no concurrent sedation & analgesia
NMBAs cause apnea and paralyze without sedating — using one without ventilation and sedation is catastrophic.
Personal/family history of malignant hyperthermia (succinylcholine)
Succinylcholine is a primary MH trigger; even a single exposure can be fatal.
Hyperkalemia risk — major burns, crush injury, denervation/spinal cord injury, myopathy (succinylcholine, after ~24–72 h)
Succinylcholine releases potassium; in these states it can cause a lethal hyperkalemic cardiac arrest.
Known pseudocholinesterase deficiency (succinylcholine) use caution
These patients cannot metabolize succinylcholine and experience dangerously prolonged paralysis.

When to hold

Assess before giving — these findings mean hold the dose and act.

Any NMBA administration
These agents paralyze without sedating or relieving pain — the patient MUST be sedated + given analgesia and have a secured airway with mechanical ventilation (the diaphragm is paralyzed → apnea).
Signs of malignant hyperthermia — rising end-tidal CO₂, rigidity, soaring temperature (succinylcholine + volatile anesthetics)
Stop the trigger and give dantrolene immediately — a hypermetabolic emergency.

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

The absolute safety bundle
Ensure the patient is sedated and receiving analgesia — never paralyze an awake patient.
Why: NMBAs cause no sedation or pain relief; without them the patient is consciously paralyzed and suffering (awareness).
Confirm a secured airway and mechanical ventilation are in place and monitored continuously.
Why: Paralysis includes the diaphragm — the patient cannot breathe; apnea is immediate and total.
Treat NMBAs as high-alert medications; store/label carefully and use independent double-checks.
Why: Accidental administration to a non-ventilated patient is rapidly fatal — a well-documented sentinel event.
Monitoring & emergencies
Monitor depth of block with train-of-four peripheral nerve stimulation.
Why: Titrating to the least paralysis needed reduces residual weakness and confirms recovery before extubation.
Have reversal agents ready — sugammadex (rocuronium/vecuronium) or neostigmine — and dantrolene available for malignant hyperthermia.
Why: Rapid reversal and MH treatment are life-saving; succinylcholine is not reversible by these agents but is short-acting.
For succinylcholine, watch for rising end-tidal CO₂, rigidity, and temperature (malignant hyperthermia) and monitor potassium in at-risk patients.
Why: Early recognition of MH and hyperkalemia allows immediate dantrolene and hyperkalemia treatment.

Sources

Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.